Review antiplatelet therapy in coronary artery disease.
Geriatric patient with coronary artery disease (CAD).
Provide antiplatelet therapy recommendations in CAD patients with/without coronary stents.
In patients with coronary artery disease:
- List the choices for antiplatelet therapy and their mechanism of action.
- List current recommendations regarding type and duration of antiplatelet therapy in patients with/without coronary stents.
- Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina), J Am Coll Cardiol 2002. 40(7) 1366-1374. http://www.ncbi.nlm.nih.gov/pubmed/12383588
- Vandvik PO, Lincoff AM, Gore JM, Gutterman DD, Sonnenberg FA, Alonso-Coello P, MD, Akl EA, Lansberg MG, Guyatt GH, Spencer FA, American College of Chest Physicians. Primary and Secondary Prevention of Cardiovascular Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012. 141(2 suppl):e637s-68s. http://www.ncbi.nlm.nih.gov/pubmed/22315274
Users are free to download and distribute Geriatric Fast Facts for informational, educational, and research purposes only. Citation: Guru Krishnan, Kathryn Denson MD, Gabriel Manzi MD, Diane Brown, Fast Fact #23: Antiplatelet Therapy in Coronary Disease, February, 2013.
Disclaimer: Geriatric Fast Facts are for informational, educational and research purposes only. Geriatric Fast Facts are not, nor are they intended to be, medical advice. Health care providers should exercise their own independent clinical judgment when diagnosing and treating patients. Some Geriatric Fast Facts cite the use of a product in a dosage, for an indication, or in a manner other than that recommended in the product labeling. Accordingly, the official prescribing information should be consulted before any such product is used.